Prince Akwasi Mensah

Array ( [id] => 3559159 [patent_doc_number] => 05500431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Tetrahydro-.beta.-carbolines' [patent_app_type] => 1 [patent_app_number] => 8/206839 [patent_app_country] => US [patent_app_date] => 1994-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27633 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500431.pdf [firstpage_image] =>[orig_patent_app_number] => 206839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3593029 [patent_doc_number] => 05488053 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'Tetrahydro-pyrido-indole' [patent_app_type] => 1 [patent_app_number] => 8/206830 [patent_app_country] => US [patent_app_date] => 1994-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18314 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/488/05488053.pdf [firstpage_image] =>[orig_patent_app_number] => 206830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604602 [patent_doc_number] => 05589197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Low sodium peritoneal dialysis solution' [patent_app_type] => 1 [patent_app_number] => 8/205304 [patent_app_country] => US [patent_app_date] => 1994-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 5134 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589197.pdf [firstpage_image] =>[orig_patent_app_number] => 205304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3556005 [patent_doc_number] => 05543434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Nasal administration of ketamine to manage pain' [patent_app_type] => 1 [patent_app_number] => 8/201756 [patent_app_country] => US [patent_app_date] => 1994-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5325 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543434.pdf [firstpage_image] =>[orig_patent_app_number] => 201756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3488253 [patent_doc_number] => 05475025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Urea derivatives useful as platelet aggregation inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/202148 [patent_app_country] => US [patent_app_date] => 1994-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10556 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/475/05475025.pdf [firstpage_image] =>[orig_patent_app_number] => 202148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624804 [patent_doc_number] => 05612374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Inhibiting growth of mammary adenocarcinoma' [patent_app_type] => 1 [patent_app_number] => 8/194857 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1783 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612374.pdf [firstpage_image] =>[orig_patent_app_number] => 194857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510404 [patent_doc_number] => 05587384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity' [patent_app_type] => 1 [patent_app_number] => 8/191508 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3584 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587384.pdf [firstpage_image] =>[orig_patent_app_number] => 191508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411388 [patent_doc_number] => 05461067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Retroviral protease inhibiting compounds' [patent_app_type] => 1 [patent_app_number] => 8/185666 [patent_app_country] => US [patent_app_date] => 1994-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45924 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/461/05461067.pdf [firstpage_image] =>[orig_patent_app_number] => 185666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754359 [patent_doc_number] => 05843481 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof' [patent_app_type] => 1 [patent_app_number] => 8/181980 [patent_app_country] => US [patent_app_date] => 1994-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7316 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843481.pdf [firstpage_image] =>[orig_patent_app_number] => 181980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3115991 [patent_doc_number] => 05449678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-12 [patent_title] => 'Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/181066 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 28 [patent_no_of_words] => 11405 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/449/05449678.pdf [firstpage_image] =>[orig_patent_app_number] => 181066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3518570 [patent_doc_number] => 05506235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Quinoline derivatives as immunostimulants' [patent_app_type] => 1 [patent_app_number] => 8/190113 [patent_app_country] => US [patent_app_date] => 1994-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15490 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 421 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/506/05506235.pdf [firstpage_image] =>[orig_patent_app_number] => 190113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926539 [patent_doc_number] => 05952357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Treating diseases of the anterior horn cells' [patent_app_type] => 1 [patent_app_number] => 8/172110 [patent_app_country] => US [patent_app_date] => 1993-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3032 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952357.pdf [firstpage_image] =>[orig_patent_app_number] => 172110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3426259 [patent_doc_number] => 05416099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-16 [patent_title] => 'Fibrinogen receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/169904 [patent_app_country] => US [patent_app_date] => 1993-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22747 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 607 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/416/05416099.pdf [firstpage_image] =>[orig_patent_app_number] => 169904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3412267 [patent_doc_number] => 05411989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-02 [patent_title] => 'Nitric acid esters of cyclohexanol derivatives' [patent_app_type] => 1 [patent_app_number] => 8/168163 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8209 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/411/05411989.pdf [firstpage_image] =>[orig_patent_app_number] => 168163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3098858 [patent_doc_number] => 05447712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'Method of reducing cyclophosphamide induced hemorrhagic cystitis' [patent_app_type] => 1 [patent_app_number] => 8/164069 [patent_app_country] => US [patent_app_date] => 1993-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 2544 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447712.pdf [firstpage_image] =>[orig_patent_app_number] => 164069 [rel_patent_id] =>[rel_patent_doc_number] =>)